Submission Requirements
Submission Requirements
Submission Requirements
[ ] For systematic review articles: a structured abstract not exceeding 200 words has been
submitted. It contains the following headings: Background; Objectives; Search strategy;
Selection criteria; Data collection and analysis; Main results; and Conclusions.
[ ] The main text adheres to the appropriate format detailed in the Guide for Authors.
[ ] For studies of patients, patient records, or volunteers: the methods include a statement that
the research protocol was approved by the relevant Institutional Review Board or Ethics
Committee before the study began. The author(s) agree to provide copies of the appropriate
documentation if requested.
[ ] If Institutional Review Board or Ethics Committee approval was not needed/obtained, an
explanation is provided in the methods.
[ ] The methods include confirmation that all human participants gave written informed consent
before the study began. The author(s) agree to provide copies of the appropriate documentation if
requested.
[ ] If informed consent was not needed/obtained, an explanation is provided in the methods.
[ ] For papers containing acknowledgments: only financialnot personalacknowledgments
have been included.
[ ] A conflict-of-interest statement has been included in the cover letter and before the reference
list in the manuscript.
[ ] All references and their citations adhere to the format detailed in the Guide for Authors.
[ ] All tables adhere to the format detailed in the Guide for Authors.
[ ] All figures and their legends adhere to the format detailed in the Guide for Authors.
[ ] I have read the IJGO policy on plagiarism (see Guide for Authors). I understand what
constitutes plagiarism and I confirm that there are no instances of plagiarism in my manuscript.
[ ] If copyright permission is required to reproduce any material in the article (in print and
online), confirmation has been included in the cover letter that such permission has been
obtained from the copyright holder; precise reference to the original work has been included at an
appropriate location in the manuscript.
[ ] For authors whose first language is not English: the manuscript has been reviewed by a
native English speaker or a professional editing service.
[ ] The manufacturers name and address (in parentheses) have been included after the name
of any instrument or equipment cited by brand name.
[ ] The generic names of all pharmaceutical preparations have been provided.
RESEARCH TYPE
[ ] Randomized controlled trial (RCT). The CONSORT statement and checklist have been
consulted: http://www.consort-statement.org/consort-statement. A CONSORT flow chart has been
submitted as an editable figure in Word/PowerPoint format.
[ ] For RCTs that began before July 1, 2005: the trial was registered prospectively or
retrospectively in a free, public clinical trial registry (see Guide for Authors regarding information
on prospective and retrospective registration). The registration number and registry website have
been listed at the end of the abstract.
[ ] For RCTs that began after July 1, 2005: the trial was registered prospectively in a free,
public clinical trial registry (see Guide for Authors regarding information on prospective and
retrospective registration). The registration number and registry website have been listed at the
end of the abstract.
[ ] Systematic review/meta-analysis. The PRISMA guidelines have been consulted:
http://www.prisma-statement.org/.
[ ]
http://www.consort-statement.org/mod_product/uploads/MOOSE%20Statement%202000.pdf.
[ ] Other type of research.